Loratadine, classified under HS code 30049039, is subject to varying Most Favored Nation (MFN) tariff rates across different countries. In the European Union (EU), which includes Slovenia, France, Finland, and Malta, the MFN tariff rate for products under HS code 30049039 is typically 0%, reflecting the EU's commitment to facilitating the importation of pharmaceutical products. Similarly, the United Kingdom maintains an MFN tariff rate of 0% for this category, aligning with its post-Brexit trade policies. The United States also imposes a 0% MFN tariff rate on pharmaceutical products under this HS code, promoting access to essential medicines. Ecuador and South Africa, however, may apply different MFN tariff rates; specific rates should be confirmed through their respective national customs authorities.
Regarding preferential rates under Free Trade Agreements (FTAs) with India, the EU and the UK do not currently have FTAs with India that alter the 0% MFN tariff rate for pharmaceutical products. The United States and India have engaged in trade discussions, but no specific FTA affecting this tariff classification has been implemented as of March 26, 2026. Ecuador and South Africa's trade agreements with India should be reviewed for any preferential rates applicable to HS code 30049039.
Exemptions for essential medicines are often provided to ensure public health needs are met. The EU, UK, and US generally exempt essential medicines from import duties, effectively maintaining a 0% tariff rate for products like Loratadine. Ecuador and South Africa may have specific provisions for essential medicines; it is advisable to consult their national customs authorities for detailed information.
